Journals / Molecular Imaging and Radionuclide Therapy / 2015 / Cilt: 24 - Sayı: 0

Meme Kanserli Olguda İzole Diffüz Deri-Deri Altı Metastazının FDG-PET/BT ile Tespiti

Detection of Isolated Diffuse Cutaneous and Subcutaneous Metastasis of Breast Cancer on FDG-PET/CT

Pages
4–6
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Histopathologic verification confirmed invasive ductal carcinoma invasion of the dermis and the lymphatic vessels

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cutaneous metastasis from internal malignancies are rare with a reported incidence between 0.7% and 10%.
📊
Key Findings & Data:We present a 53-year-old woman with a history of bilateral breast cancer who underwent FDG-PET/CT for re-staging, which demonstrated isolated cutaneous and subcutaneous chest wall metastases.
💡
Conclusion & Impact:Histopathologic verification confirmed invasive ductal carcinoma invasion of the dermis and the lymphatic vessels
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cutaneous metastasis from internal malignancies are rare with a reported incidence between 0.7% and 10%. The most common tumor that metastasize to the skin is breast cancer. We present a 53-year-old woman with a history of bilateral breast cancer who underwent FDG-PET/CT for re-staging, which demonstrated isolated cutaneous and subcutaneous chest wall metastases. Histopathologic verification confirmed invasive ductal carcinoma invasion of the dermis and the lymphatic vessels

Özet

İç organ malignitelerinin deri metastazları nadir olup sıklığı %0,7 ve %10 arasındadır. Deri metastazının yaygın olarak meme kanserinde olduğu kabul edilir. Sunduğumuz olguda; bilateral meme kanserli 53 yaşındaki kadın hastaya yeniden evreleme için uygulanan FDG-PET/BT ile, izole deri-deri altı, göğüs duvarı metastazı gösterildi. Bu lezyonların invaziv duktal karsinomun deri ve lenfatiklere invazyonu olduğu histopatolojik olarak doğrulandı

🔖

Cite This Article

TAMAM, M. Ö., TOPUZ, Ö. V., EKMEKÇİ, T. R., KAMALI, G., MÜLAZIMOĞLU, M. (2015). Meme Kanserli Olguda İzole Diffüz Deri-Deri Altı Metastazının FDG-PET/BT ile Tespiti. Molecular Imaging and Radionuclide Therapy, Cilt: 24 - Sayı: 0, 4–6. https://ajindex.com/articles/295239

References (14)

  1. Sariya D, Ruth K, Adams-McDonnell R, Cusack C, Xu X, Elenitsas R, Seykora J, Pasha T, Zhang P, Baldassano M, Lessin SR, Wu H. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center. Arch Dermatol 2007;143:613-620
  2. G Nava, K Greer, J Patterson, KY Lin. Metastatic cutaneous breast carcinoma: A case report and review of the literature. Can J Plast Surg 2009;17:25-27.
  3. Manohar K, Mittal BR, Bhattacharya A, Singh G. Asymptomatic Distant Subcutaneous Metastases Detected by (18)F-FDG-PET/CT in a Patient with Breast Carcinoma. World J Nucl Med 2012;11:24-25.
  4. El Khoury J, Khalifeh I, Kibbi AG, Abbas O. Cutaneous metastasis: clinicopathological study of 72 patients from a tertiary care center in Lebanon.Int J Dermatol 2014;53:147-158.
  5. Cox SE, Cruz PD Jr. A spectrum of inflammatory metastasis to skin via lymphatics: three cases of carcinoma erysipeloides. J Am Acad Dermatol 1994;30:304-307.
  6. Manohar K, Mittal BR, Bhoil A, Bhattacharya A, Singh G. Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer. Nucl Med Commun 2013;34:557-561.
  7. Blumer SL, Scalcione LR, Ring BN, Johnson R, Motroni B, Katz DS, Yung EY. Cutaneous and subcutaneous imaging on FDG-PET: benign and malignant findings. Clin Nucl Med 2009;34:675-683.
  8. Nguyen NC, Chaar BT, Osman MM. Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT. BMC Med Imaging 2007;7:8. Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta- analysis of data. South Med J 2003;96:164-167.
  9. Borkar S, Pandit-Taskar N. F-18 FDG uptake in cutaneous metastases from breast cancer.Clin Nucl Med 2008;33:488-489.
  10. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993;29:228-236.
  11. Hoffmann M, Oberhuber G, Kletter K, Becherer A, Raderer M. Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography. Clin Nucl Med 2002;27:731-732.
  12. Gemmel F, Roosjen H, van der Wijk P, Collins J. Subcutaneous metastasis from an occult esophageal cancer detected by PET-CT. Clin Nucl Med 2008;33:866-867.
  13. Hyun IY, Yun MY. FDG uptake in cutaneous and subcutaneous metastases from colorectal adenocarcinoma. Clin Nucl Med 2010;35:93-94.
  14. Tamam MO, Mulazimoglu M, Aydin T. Subcutaneous and intramuscular metastases of cervix cancer detected with 18F-fluoro-2- deoxyglucose p